Optimizing Glaucoma Management: Clinical and Cost Concerns for Managed Care

Slide Lecture with Audio/Monograph

Sponsored by North American Center for Continuing Medical Education, LLC

Presenters/Q&A Cohosts

Robert D. Fechtner, MD
Professor of Ophthalmology
Director, Glaucoma Division
Institute of Ophthalmology and Visual Science
New Jersey Medical School, UMDNJ
Newark, New Jersey

Clark Springs, MD
Assistant Professor
Director, Cornea and Refractive Surgery
Glick Eye Institute
Indiana University School of Medicine
Indianapolis, Indiana

Q&A Cohost

Randall Seifert, PharmD
Professor, Department of Pharmacy Practice and Pharmaceutical Sciences
Senior Associate Dean
University of Minnesota
College of Pharmacy
Minneapolis, Minnesota

Learning Objectives

After completing this activity, participants should be able to:

Chart the total clinical and economic burden of glaucoma and disease sequelae
Describe the importance of early diagnosis and impact of early treatment on long-term glaucoma outcomes
Interpret and apply emerging data on the safety and efficacy of available glaucoma medications
Promote evidence-based glaucoma management practices among in-plan ophthalmologists to improve outcomes

Target Audience

This activity is designed for managed markets physicians and pharmacists.

Activity Overview

This slide lecture with audio is available with html slides and the presentation transcript. The monograph is available in print and PDF format.

To be eligible for documentation of credit, participants must complete one of the educational activities, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for these enduring materials.

This educational activity is a knowledge-based activity.

Release Date: March 18, 2010

Expiration Date: June 10, 2011

Estimated time to complete: 1 hour

For questions regarding this activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-10-004-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review

Independent Clinical Reviewer: Simon K. Law, MD, PharmD, Associate Professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California

Medical writer Deborah Neveleff contributed to the writing and editing of the monograph article.

Planning Committee

The planning committee comprises Robert D. Fechtner, MD, Simon K. Law, MD, PharmD, Randall Seifert, PharmD, Clark Springs, MD; Kristin Dickie, Mary Johnson, Mike Kearney, Deborah Neveleff, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Fechtner: Grant/research support—Allergan, Inc; Consultant—Alcon Laboratories, Inc, Allergan, Inc
Dr. Law: Grant/research support—Allergan, Inc; Promotional speakers bureau—Allergan, Inc
Dr. Springs: Grant/research support—Alcon Laboratories, Inc, Inspire; Consultant—Alcon Laboratories, Inc, Allergan, Inc, Ista Pharmaceuticals, Inc, Santen Pharmaceutical; Scientific advisor—Alcon Laboratories, Inc, Ista Pharmaceuticals; Promotional speakers bureau—Alcon Laboratories, Inc, Allergan, Inc, Inspire
Dr. Seifert: Consultant—Alcon Laboratories, Inc; Employee/officer/board member—Seifert and Associates, SPC Therapeutics

Ms. Dickie, Ms. Johnson, Mr. Kearney, Ms. Neveleff, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Alcon Laboratories, Inc.